LORRAINE OLIVERO-BRODEUR: Open Payments
NPI 1033294301 · WEST NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,309 in 108 payments from 16 companies in 2025. Trend: 2023 $1,929 · 2024 $2,642 · 2025 $2,309
Food & beverage: $2,219Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $576 |
| GlaxoSmithKline, LLC. | 24 | $449 |
| GENZYME CORPORATION | 14 | $295 |
| Regeneron Healthcare Solutions, Inc. | 9 | $158 |
| Viatris Specialty LLC | 6 | $125 |
| Amgen Inc. | 6 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Insmed, Inc. | 3 | $66 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, YUPELRI, GLASSIA, FASENRA.
Industry payments across NY — which companies pay providers there.
